CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
34 hedge funds and large institutions have $45.5M invested in Cymabay Therapeutics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 10 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
34
Holders Change
+7
Holders Change %
+25.93%
% of All Funds
0.85%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
15
Increased
10
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
![]()
1
Adage Capital Partners
Boston,
Massachusetts
|
$7.91M |
2 |
BBA
2
Baker Bros. Advisors
New York
|
$6.08M |
3 |
BC
3
Boxer Capital
San Diego,
California
|
$3.34M |
4 |
GTC
4
Ghost Tree Capital
New York
|
$2.15M |
5 |
JGC
5
J. Goldman & Co
New York
|
$3.12M |